Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun-Yan Liu

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Free Radical Biology & Medicine|January 24, 2025
Salvianolic acid B drives gluconeogenesis and peroxisomal redox remodeling in cardiac ischemia/reperfusion injury: A metabolism regulation by metabolite signal crosstalkJin-Shan Li, Xiao-Ming Qi, Qing-Fang Li, et al.
Cancer Letters|April 2, 2016
Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patientsJia-Jia Liu, Jun-Yan Liu, Jun Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasisGuodong Zhang, Dipak Panigrahy, Sung Hee Hwang, et al.
International Journal of Biological Sciences|January 29, 2026
Targeting CDC42 Protects Mitochondrial Function through KLF2/HIF-1α/PINK1 Signaling in Acute Kidney InjuryXue Zhou, Xian Fu, Yi-Wen Meng, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2024
Metabolomics reveals soluble epoxide hydrolase as a therapeutic target for high-sucrose diet-mediated gut barrier dysfunctionAi-Zhi Lin, Xian Fu, Qing Jiang, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 13, 2010
M. tuberculosis H37Rv infection of Chinese rhesus macaquesJing Zhang, Yan-Qing Ye, Yong Wang, et al.
Biochemical Pharmacology|May 22, 2021
The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repairJuan Chen, Jun-Yan Liu, Zi-Zheng Dong, et al.
Cancer Research|June 24, 2021
<i>Fusobacterium Nucleatum</i> Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 SignalingCheng Kong, Xuebing Yan, Yefei Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2019
Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPKYing Luo, Ming-Yu Wu, Bing-Qing Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2018
Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammationWeicang Wang, Jun Yang, Jianan Zhang, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Free Radical Biology & Medicine|January 24, 2025
Salvianolic acid B drives gluconeogenesis and peroxisomal redox remodeling in cardiac ischemia/reperfusion injury: A metabolism regulation by metabolite signal crosstalkJin-Shan Li, Xiao-Ming Qi, Qing-Fang Li, et al.
Cancer Letters|April 2, 2016
Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patientsJia-Jia Liu, Jun-Yan Liu, Jun Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasisGuodong Zhang, Dipak Panigrahy, Sung Hee Hwang, et al.
International Journal of Biological Sciences|January 29, 2026
Targeting CDC42 Protects Mitochondrial Function through KLF2/HIF-1α/PINK1 Signaling in Acute Kidney InjuryXue Zhou, Xian Fu, Yi-Wen Meng, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2024
Metabolomics reveals soluble epoxide hydrolase as a therapeutic target for high-sucrose diet-mediated gut barrier dysfunctionAi-Zhi Lin, Xian Fu, Qing Jiang, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 13, 2010
M. tuberculosis H37Rv infection of Chinese rhesus macaquesJing Zhang, Yan-Qing Ye, Yong Wang, et al.
Biochemical Pharmacology|May 22, 2021
The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repairJuan Chen, Jun-Yan Liu, Zi-Zheng Dong, et al.
Cancer Research|June 24, 2021
<i>Fusobacterium Nucleatum</i> Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 SignalingCheng Kong, Xuebing Yan, Yefei Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2019
Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPKYing Luo, Ming-Yu Wu, Bing-Qing Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2018
Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammationWeicang Wang, Jun Yang, Jianan Zhang, et al.
Pageof 15